Cargando…

Microvasculopathy Evaluated by Dual-Energy Computed Tomography in Patients with Chronic Thromboembolic Pulmonary Hypertension and Pulmonary Arterial Hypertension

Background: Poor subpleural perfusion (PSP) on dual-energy computed tomography (DE-CT) suggests microvasculopathy in chronic thromboembolic pulmonary hypertension (CTEPH). However, whether the microvasculopathy findings are equivalent to those in pulmonary arterial hypertension (PAH) remains unclear...

Descripción completa

Detalles Bibliográficos
Autores principales: Miwa, Keisuke, Taniguchi, Yu, Fujii, Hiroyuki, Matsuoka, Yoichiro, Onishi, Hiroyuki, Yanaka, Kenichi, Izawa, Yu, Tsuboi, Yasunori, Kono, Atsushi, Emoto, Noriaki, Hirata, Kenichi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9410450/
https://www.ncbi.nlm.nih.gov/pubmed/36013412
http://dx.doi.org/10.3390/life12081232
_version_ 1784775096253022208
author Miwa, Keisuke
Taniguchi, Yu
Fujii, Hiroyuki
Matsuoka, Yoichiro
Onishi, Hiroyuki
Yanaka, Kenichi
Izawa, Yu
Tsuboi, Yasunori
Kono, Atsushi
Emoto, Noriaki
Hirata, Kenichi
author_facet Miwa, Keisuke
Taniguchi, Yu
Fujii, Hiroyuki
Matsuoka, Yoichiro
Onishi, Hiroyuki
Yanaka, Kenichi
Izawa, Yu
Tsuboi, Yasunori
Kono, Atsushi
Emoto, Noriaki
Hirata, Kenichi
author_sort Miwa, Keisuke
collection PubMed
description Background: Poor subpleural perfusion (PSP) on dual-energy computed tomography (DE-CT) suggests microvasculopathy in chronic thromboembolic pulmonary hypertension (CTEPH). However, whether the microvasculopathy findings are equivalent to those in pulmonary arterial hypertension (PAH) remains unclear. The aim of this study was to elucidate the characteristics of microvasculopathy in CTEPH compared to those of that in PAH. Methods: We retrospectively reviewed subpleural perfusion on DE-CT and the hemodynamics of 23 patients with PAH and 113 with inoperable CTEPH. Subpleural perfusion on DE-CT was classified as poor (subpleural spaces in all segments with little or no perfusion) or normal. Results: PSP was observed in 51% of patients with CTEPH and in 4% of those with PAH (p < 0.01). CTEPH patients with PSP had poorer baseline hemodynamics and lower diffusing capacity for carbon monoxide divided by the alveolar volume (DLCO/VA) than those with CTEPH with normal perfusion (pulmonary vascular resistance [PVR]: 768 ± 445 dynes-sec/cm(5) vs. 463 ± 284 dynes-sec/cm(5), p < 0.01; DLCO/VA, 60.4 ± 16.8% vs. 75.9 ± 15.7%, p < 0.001). Despite the existence of PSP, hemodynamics improved to nearly normal in both groups after balloon pulmonary angioplasty. Conclusions: PSP on DE-CT, which is one of the specific imaging findings in CTEPH, might suggest a different mechanism of microvasculopathy from that in PAH.
format Online
Article
Text
id pubmed-9410450
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-94104502022-08-26 Microvasculopathy Evaluated by Dual-Energy Computed Tomography in Patients with Chronic Thromboembolic Pulmonary Hypertension and Pulmonary Arterial Hypertension Miwa, Keisuke Taniguchi, Yu Fujii, Hiroyuki Matsuoka, Yoichiro Onishi, Hiroyuki Yanaka, Kenichi Izawa, Yu Tsuboi, Yasunori Kono, Atsushi Emoto, Noriaki Hirata, Kenichi Life (Basel) Article Background: Poor subpleural perfusion (PSP) on dual-energy computed tomography (DE-CT) suggests microvasculopathy in chronic thromboembolic pulmonary hypertension (CTEPH). However, whether the microvasculopathy findings are equivalent to those in pulmonary arterial hypertension (PAH) remains unclear. The aim of this study was to elucidate the characteristics of microvasculopathy in CTEPH compared to those of that in PAH. Methods: We retrospectively reviewed subpleural perfusion on DE-CT and the hemodynamics of 23 patients with PAH and 113 with inoperable CTEPH. Subpleural perfusion on DE-CT was classified as poor (subpleural spaces in all segments with little or no perfusion) or normal. Results: PSP was observed in 51% of patients with CTEPH and in 4% of those with PAH (p < 0.01). CTEPH patients with PSP had poorer baseline hemodynamics and lower diffusing capacity for carbon monoxide divided by the alveolar volume (DLCO/VA) than those with CTEPH with normal perfusion (pulmonary vascular resistance [PVR]: 768 ± 445 dynes-sec/cm(5) vs. 463 ± 284 dynes-sec/cm(5), p < 0.01; DLCO/VA, 60.4 ± 16.8% vs. 75.9 ± 15.7%, p < 0.001). Despite the existence of PSP, hemodynamics improved to nearly normal in both groups after balloon pulmonary angioplasty. Conclusions: PSP on DE-CT, which is one of the specific imaging findings in CTEPH, might suggest a different mechanism of microvasculopathy from that in PAH. MDPI 2022-08-15 /pmc/articles/PMC9410450/ /pubmed/36013412 http://dx.doi.org/10.3390/life12081232 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Miwa, Keisuke
Taniguchi, Yu
Fujii, Hiroyuki
Matsuoka, Yoichiro
Onishi, Hiroyuki
Yanaka, Kenichi
Izawa, Yu
Tsuboi, Yasunori
Kono, Atsushi
Emoto, Noriaki
Hirata, Kenichi
Microvasculopathy Evaluated by Dual-Energy Computed Tomography in Patients with Chronic Thromboembolic Pulmonary Hypertension and Pulmonary Arterial Hypertension
title Microvasculopathy Evaluated by Dual-Energy Computed Tomography in Patients with Chronic Thromboembolic Pulmonary Hypertension and Pulmonary Arterial Hypertension
title_full Microvasculopathy Evaluated by Dual-Energy Computed Tomography in Patients with Chronic Thromboembolic Pulmonary Hypertension and Pulmonary Arterial Hypertension
title_fullStr Microvasculopathy Evaluated by Dual-Energy Computed Tomography in Patients with Chronic Thromboembolic Pulmonary Hypertension and Pulmonary Arterial Hypertension
title_full_unstemmed Microvasculopathy Evaluated by Dual-Energy Computed Tomography in Patients with Chronic Thromboembolic Pulmonary Hypertension and Pulmonary Arterial Hypertension
title_short Microvasculopathy Evaluated by Dual-Energy Computed Tomography in Patients with Chronic Thromboembolic Pulmonary Hypertension and Pulmonary Arterial Hypertension
title_sort microvasculopathy evaluated by dual-energy computed tomography in patients with chronic thromboembolic pulmonary hypertension and pulmonary arterial hypertension
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9410450/
https://www.ncbi.nlm.nih.gov/pubmed/36013412
http://dx.doi.org/10.3390/life12081232
work_keys_str_mv AT miwakeisuke microvasculopathyevaluatedbydualenergycomputedtomographyinpatientswithchronicthromboembolicpulmonaryhypertensionandpulmonaryarterialhypertension
AT taniguchiyu microvasculopathyevaluatedbydualenergycomputedtomographyinpatientswithchronicthromboembolicpulmonaryhypertensionandpulmonaryarterialhypertension
AT fujiihiroyuki microvasculopathyevaluatedbydualenergycomputedtomographyinpatientswithchronicthromboembolicpulmonaryhypertensionandpulmonaryarterialhypertension
AT matsuokayoichiro microvasculopathyevaluatedbydualenergycomputedtomographyinpatientswithchronicthromboembolicpulmonaryhypertensionandpulmonaryarterialhypertension
AT onishihiroyuki microvasculopathyevaluatedbydualenergycomputedtomographyinpatientswithchronicthromboembolicpulmonaryhypertensionandpulmonaryarterialhypertension
AT yanakakenichi microvasculopathyevaluatedbydualenergycomputedtomographyinpatientswithchronicthromboembolicpulmonaryhypertensionandpulmonaryarterialhypertension
AT izawayu microvasculopathyevaluatedbydualenergycomputedtomographyinpatientswithchronicthromboembolicpulmonaryhypertensionandpulmonaryarterialhypertension
AT tsuboiyasunori microvasculopathyevaluatedbydualenergycomputedtomographyinpatientswithchronicthromboembolicpulmonaryhypertensionandpulmonaryarterialhypertension
AT konoatsushi microvasculopathyevaluatedbydualenergycomputedtomographyinpatientswithchronicthromboembolicpulmonaryhypertensionandpulmonaryarterialhypertension
AT emotonoriaki microvasculopathyevaluatedbydualenergycomputedtomographyinpatientswithchronicthromboembolicpulmonaryhypertensionandpulmonaryarterialhypertension
AT hiratakenichi microvasculopathyevaluatedbydualenergycomputedtomographyinpatientswithchronicthromboembolicpulmonaryhypertensionandpulmonaryarterialhypertension